Progress in blood biomarkers of subjective cognitive decline in preclinical Alzheimer's disease
Progress in blood biomarkers of subjective cognitive decline in preclinical Alzheimer's disease
About this item
Full title
Author / Creator
Yu, Xianfeng , Shao, Kai , Wan, Ke , Li, Taoran , Li, Yuxia , Zhu, Xiaoqun and Han, Ying
Publisher
China: Lippincott Williams & Wilkins
Journal title
Language
English
Formats
Publication information
Publisher
China: Lippincott Williams & Wilkins
Subjects
More information
Scope and Contents
Contents
Alzheimer's disease (AD) is a neurodegenerative disease that gradually impairs cognitive functions. Recently, there has been a conceptual shift toward AD to view the disease as a continuum. Since AD is currently incurable, effective intervention to delay or prevent pathological cognitive decline may best target the early stages of symptomatic disea...
Alternative Titles
Full title
Progress in blood biomarkers of subjective cognitive decline in preclinical Alzheimer's disease
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_25f2ab900f774fb387f491c3802a31cc
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_25f2ab900f774fb387f491c3802a31cc
Other Identifiers
ISSN
0366-6999,2542-5641
E-ISSN
2542-5641
DOI
10.1097/CM9.0000000000002566
